MS drug successfully prevented relapse symptoms, say Biogen and Abbott
Earlier on Tuesday, Biogen Idec Inc. and Abbott Laboratories announced that the results of a mid-stage clinical trial revealed that
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine